Risk of recurrence and bleeding in patients with cancer‐associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study

BACKGROUND: Rivaroxaban could be an attractive alternative to low molecular weight heparin for the treatment of cancer‐associated venous thromboembolism (VTE) but the safety and effectiveness remain unclear. We examined risk of recurrent VTE and major bleeding associated with rivaroxaban treatment o...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Med
Main Authors: Søgaard, Mette, Nielsen, Peter Brønnum, Skjøth, Flemming, Kjældgaard, Jette Nordstrøm, Larsen, Torben Bjerregaard
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Clinical Cancer Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6434207/
https://ncbi.nlm.nih.gov/pubmed/30767432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1997
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker